American Association for Cancer Research

SHERPA: Unknown

People

  1. Houghton
    Houghton
  2. Panageas
    Panageas
  3. Perales
    Perales
  4. Hirschhorn Cymerman
    Hirschhorn Cymerman
  5. Liu
    Liu
  6. Rosen
    Rosen
  7. Solit
    Solit
  8. Terzulli
    Terzulli
  9. Busam
    Busam
  10. Norton
    Norton

Groups

  1. Immunology Program Faculty (49)
  2. Sloan Kettering Institute Faculty (49)
  3. Department of Medicine (36)
  4. Solid Tumor Oncology Division (35)
  5. Melanoma and Immunotherapeutics Service (32)
  6. GSK Faculty (25)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (17)
  8. Hematologic Malignancies, Division of (16)
  9. Center for Hematologic Malignancies (13)
  10. Bone Marrow Transplant (8)
Search Within
  1. "Alan Houghton"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (16)
Groups
  1. Immunology Program Faculty (49)
  2. Sloan Kettering Institute Faculty (49)
  3. Department of Medicine (36)
  4. Solid Tumor Oncology Division (35)
  5. Melanoma and Immunotherapeutics Service (32)
  6. GSK Faculty (25)

More Groups

People
  1. Alan Houghton (49)
  2. Jedd Wolchok (21)
  3. Paul Chapman (13)
  4. Taha Merghoub (8)
  5. Katherine Panageas (7)
  6. Philip Livingston (6)

More People

Years
  1. 2022 (1)
  2. 2013 (1)
  3. 2012 (1)
  4. 2011 (2)
  5. 2010 (2)
  6. 2009 (3)

More Years

Publications
  1. Cancer Research (26)
  2. Clinical Cancer Research (23)

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination of cyclophosphamide with immune checkpoint blockade inhibition elicits potent tumor control in a preclinical melanoma model
    Meeting Abstract

    George, M. M.; Warner, A. B.; Hamadene, L.; Hirschhorn, D.; Houghton, A. N.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Therapeutic efficacy of antitumor monoclonal antibodies combined with chemotherapy depends on innate immunity and NK1.1-innate lymphoid cells
    Meeting Abstract

    Moskalenko, M.; Pan, M.; Hashimoto, D.; Mortha, A.; Bernardo, S. G.; Leboeuf, M.; Houghton, A.; Wolchok, J.; Burakoff, S.; Merad, M.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment
    Journal Article

    Lesokhin, A. M.; Hohl, T. M.; Kitano, S.; Cortez, C.; Hirschhorn-Cymerman, D.; Avogadri, F.; Rizzuto, G. A.; Lazarus, J. J.; Pamer, E. G.; Houghton, A. N.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Anti-tyrosinase related protein 1 (TRP1) antibody combined with cyclophosphamide induces adaptive immunity against melanoma
    Meeting Abstract

    Saenger, Y. M.; Pan, M.; Hashimoto, D.; Glodny, B.; Shah, S.; Houghton, A. N.; Merghoub, T.; Wolchok, J. D.; Merad, M.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Peptide-loaded langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo
    Journal Article

    Romano, E.; Rossi, M.; Ratzinger, G.; De Cos, M. A.; Chung, D. J.; Panageas, K. S.; Wolchok, J. D.; Houghton, A. N.; Chapman, P. B.; Heller, G.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Concurrent loss of PTEN and RB is sufficient to confer BRAF independence in melanomas harboring V600E BRAF mutations
    Meeting Abstract

    Xing, F.; Persaud, Y.; Pratilas, C.; Janakiraman, M.; She, Q. B.; Liu, C.; Dolgalev, I.; Heguy, A.; Wolchok, J.; Cobrinik, D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Immunologic response to xenogeneic gp100 DNA in melanoma patients: Comparison of particle-mediated epidermal delivery with intramuscular injection
    Journal Article

    Ginsberg, B. A.; Gallardo, H. F.; Rasalan, T. S.; Adamow, M.; Mu, Z.; Tandon, S.; Bewkes, B. B.; Roman, R. A.; Chapman, P. B.; Schwartz, G. K.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Safety and immunogenicity of gp100 DNA vaccines in patients with melanoma
    Meeting Abstract

    Yuan, J.; Ku, G. Y.; Gallardo, H. F.; Orlandi, F.; Manukian, G.; Rasalan, T.; Li, H.; Xu, Y.; Vyas, S.; Mu, Z.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Genetic predictors of MEK dependence in V600E BRAF mutant melanoma
    Meeting Abstract

    Xing, F.; Pratilas, C.; Persaud, Y.; Janakiraman, M.; Houghton, A.; Rosen, N.; Solit, D.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Immune rejection of mouse tumors expressing mutated self
    Journal Article

    Duan, F.; Lin, Y.; Liu, C.; Engelhorn, M. E.; Cohen, A. D.; Curran, M.; Sakaguchi, S.; Merghoub, T.; Terzulli, S.; Wolchok, J. D.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: